Mobile Health Technology for Palliative Care Patients

Metastatic Cancer Clinical Trial

Official title:

Mobile Health Technologies for Palliative Care Patients at the Interface of In-patient to Out-patient Care: A Feasibility Study Aiming to Early Predict Deterioration of Patient's Health Status

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03038841
• Other study ID #: PC 16/16
• Status: Recruiting
• Phase: N/A
• First received: January 25, 2017
• Last updated: June 20, 2017
• Start date: February 1, 2017
• Est. completion date: May 31, 2018

Study information

• Verified date: January 2017
• Source: University of Zurich
• Contact: Gudrun Theile, MD
• Phone: +41 44 255 5495
• Email: gudrun.theile[@]usz.ch
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

To test the potential and acceptance of wireless activity tracking in palliative care patients leaving hospital care. Explorative study, collaboration project of the Clinic of Radiation-Oncology, University Hospital Zurich and the Wearable Computing Laboratory, Swiss Federal Institut of Technology. Patients receive a tracking bracelet and a smart phone in order to gather objective physical activity parameters as step count, sleep duration, heart rate, social activity patterns (e.g. making calls) as well as subjective ratings of pain and distress. Quality of life (QoL) will be captured by paper questionnaire. Correlations between patients' physical activity patterns and the pain and distress level assessed from electronic scales as well as QoL-questionnaire will be performed. Acceptance will be evaluated by quantitative questionnaires and interviews. The proposed study is meant to be preparatory work for an intervention study to test the effect of wireless monitoring of palliative care patients on fostering early interventions for symptom relief and support of QoL.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 30
• Est. completion date: May 31, 2018
• Est. primary completion date: May 31, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 105 Years

Eligibility

Inclusion Criteria:

• established diagnosis of metastatic cancer or other severe illness with limited life-expectancy (physicians guess <12 months, > 8 weeks)

• Karnofsky Index =50%

• ECOG= 2

• aged > 18 years

• passed a short handling test with devices (tracking bracelet, smart phone)

Exclusion Criteria:

• relevant cognitive impairment

• insufficient knowledge of German language.

Related Conditions & MeSH terms

• Chronic Disease
• Metastatic Cancer
• Mobile Health
• Neoplasm Metastasis

Intervention

Device:
• Mobile Health
Patients discharged from hospital will be equipped with a tracking bracelet and a smart phone

Locations

Country	Name	City	State
Switzerland	Clinic of Radiation-Oncology University Hospital Zurich	Zürich	Zurich

Sponsors (3)

Lead Sponsor	Collaborator
University of Zurich	Swiss Academy of Medical Sciences (SAMS), Swiss Federal Institute of Technology

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Feasibility (time of complete data transfer in weeks)	time of complete data transfer in weeks	12 weeks